SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Colby who wrote (10325)7/1/1998 6:05:00 PM
From: Mkilloran  Respond to of 23519
 
colby...I agree Vivus could turn over the marketing in the USA just as they have in all overseas markets...this would have a quick bost in sales and stock value.

If they don't act now ...then the proof will come as Astra and Janssen go head to head with Viagra in the oversea markets...
Muse/Alibra will hold onto a much bigger piece of the ED market than has been seen todate in the USA.

3rd and 4th qtr will show a good profit and rise in the stock price.